October 09, 2015
Drugmakers Helsinn Healthcare SA and Roche Palo Alto LLC hit two generics makers with a patent suit Thursday over their application for U.S. Food and Drug Administration approval of a version of Helsinn's Aloxi, an intravenous treatment for nausea caused by chemotherapy.